Evofem Biosciences
Ron Koenig is an accomplished sales professional with extensive experience in the pharmaceutical and medical services sectors. Currently serving as an Executive Specialty Sales Representative at Evofem Biosciences since August 2020, Ron has previously held roles including Neurology Specialty Sales Representative at Amneal Pharmaceuticals, Business Development Manager at Athena Medical Services, and Senior Sales Specialist in Women's Health at Teva Pharmaceuticals. Ron's career encompasses team management and training as a District Manager with Centrix Pharmaceuticals and DURAMED/BARR PHARMACEUTICALS, as well as account management and sales leadership at Pepsi Cola. Ron holds a Bachelor's degree in Business Administration from Lindenwood University.
This person is not in any teams
This person is not in any offices
Evofem Biosciences
1 followers
Evofem Biosciences, Inc., (NASDAQ: EVFM) is a commercial-stage biopharmaceutical company committed to developing and commercializing innovative products to address unmet needs in women's sexual and reproductive health, including hormone-free, woman-controlled contraception and protection from certain sexually transmitted infections (STIs). The Company's first commercial product, Phexxi®, is the first and only hormone-free, prescription vaginal gel approved in the United States for the prevention of pregnancy. The Company’s lead product candidate, EVO100, is being evaluated for the prevention of urogenital Chlamydia trachomatis and Neisseria gonorrhoeae infection in women in the ongoing Phase 3 clinical trial, ‘EVOGUARD.’